NCNA News and Press, NuCana plc From 11/10/23

2023-11-10 16:06:50 ET More on NuCana NuCana Q2 Earnings: Recent Updates Bode Poorly, Not Worth The Risk For further details see: NuCana gets approval to transfer its listing to Nasdaq Capital Market

EDINBURGH, United Kingdom, Nov. 10, 2023 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) announced today that it has received approval from Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) to transfer the l...

EDINBURGH, United Kingdom, Nov. 01, 2023 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will host one-on-one meetings at the Truist Securities 2023 BioPharma Symposium. Event: Truist Securiti...

Data from the NuTide:701 Study Indicate NUC-7738 May Potentiate the Activity of Anti-PD-1 Agents in Patients who were Refractory to or Progressed on Prior Immunotherapy, including Anti-PD-1 Therapy Several Patients Achieved Reductions in Tumor Volume and Prolonged Time on Treatment ...

NUC-3373 Demonstrates Promising Anti-Tumor Activity and a Favorable Safety Profile as part of NUFIRI-bevacizumab and NUFOX-bevacizumab in Second-line Colorectal Cancer Patients Several Second-line Colorectal Cancer Patients in the NuTide:302 Study Achieved a Longer Progression-Free Su...

2023-10-10 09:29:53 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Akero Therapeutics (NASDAQ: AKRO ) stock is falling hard on Tuesday after the company failed to impress investors with its latest clinical trial results. The bad news comes ...

2023-10-10 09:03:36 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Rivian Automotive (NASDAQ: RIVN ) stock is in the news Tuesday after analysts at UBS upgraded the electric vehicle (EV) company’s shares. That upgrade has UBS analyst...

2023-10-10 08:46:20 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips NuCana (NASDAQ: NCNA ) stock is sliding lower on Tuesday as the clinical-stage biopharmaceutical company prepares for a presentation this week . NuCana is set to attend ...

EDINBURGH, United Kingdom, Sept. 18, 2023 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced four presentations at the upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 being held October 11-15, 2023 in Boston, Massachusetts. The details o...

2023-08-17 06:53:06 ET Summary NuCana is working toward improved chemotherapies for cancer. Early trials to date show some glimmers of promise, but high-profile failures and deficient study design cast a pall on the entire platform. Cash issues present near-term challenges for...